abstract |
The present invention provides 1-[(3R)-3-[4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-D]pyrimidin-1-yl]-1- Anhydrous, hydrate and solvate new crystal forms of piperidinyl]-2-propen-1-one and a preparation method thereof. The several new crystal forms provided by the present invention can be used to treat various diseases, especially the diseases that can be used to treat mantle cell lymphoma. |